Veterans Affairs has had some ups and downs since launching CRADA

April 2008
Clinical Trials Administrator;Apr2008, Vol. 6 Issue 4, p37
The article reports that the implementation of Cooperative Research and Development Agreements (CRADA) by the U.S. Department of Veterans Affairs (VA) for clinical trials could prove to be a model for the clinical research industry. Clinical research experts have been lobbying for sponsors and clinical trial sites to expedite the negotiating process, which have been a key factor in the industry's long research delays. Amy Centani, director of technology transfer at VA says, all clinical trials need to be done through a CRADA.


Related Articles

  • VA Putting "Point-of-Care Research" to the Test.  // Biomedical Market Newsletter;5/9/2011, p8 

    The article reports on a point-of-care clinical study, which is under development by a team from the U.S. Department of Veterans Affairs (VA) and Stanford University involving more than 3,000 Veterans with diabetes. According to Joel Kupersmith, VA's chief research and development (R&D) officer,...

  • Standards and Surveillance. Wechsler, Jill // Applied Clinical Trials;Jun2001, Vol. 10 Issue 6, p30 

    Reports that public and private organizations are developing accreditation standards for research entities that could affect the United States Food and Drug Administration's oversight of clinical studies. Recommendation for the establishment of an accreditation system by the Institute of...

  • Robotics and clinical research: Collaborating to expand the evidence base for rehabilitation. Huang, Grant D.; Peduzzi, Peter; Kerkovich, Danielle // Journal of Rehabilitation Research & Development;Aug/Sep2006, Vol. 43 Issue 5, pxiii 

    This article focuses on medical robotics research performed by the U. S. Department of Veterans Affairs (VA). The article presents examples of how the VA has put its experience in conducting clinical trials to use in collaboration with experts in neurorehabilitation in a novel trial that employs...

  • The role of economics in the QUERI program: QUERI Series. Smith, Mark W.; Barnett, Paul G. // Implementation Science;2008, Vol. 3, Special section p1 

    Background: The United States (U.S.) Department of Veterans Affairs (VA) Quality Enhancement Research Initiative (QUERI) has implemented economic analyses in single-site and multi-site clinical trials. To date, no one has reviewed whether the QUERI Centers are taking an optimal approach to doing...

  • Otonomy Tackles Hearing and Balance Disorders.  // Bioworld Week;3/30/2009, Vol. 17 Issue 13, p2 

    The article reports on the founding of Otonomy Inc., a pharmaceutical company in California launched by Jay Lichter and Jeffrey Harris which creates a gel formulation of dexamethasone to treat hearing and balance disorders such as Meniere's disease. It notes the plan of the Otonomy Inc. to begin...

  • Capsule Commentary on Oslin et al., A Randomized Clinical Trial of Alcohol Care Management Delivered in Department of Veterans Affairs Primary Care Clinics Versus Specialty Addiction Treatment. Malte, Carol // JGIM: Journal of General Internal Medicine;Jan2014, Vol. 29 Issue 1, p184 

    The article presents a commentary on the research study on the randomized clinical trial of alcohol care management delivered in Department of Veterans Affairs Primary Care Clinics on specialty alcohol addiction treatment. It mentions the health implications of alcohol use disorders (AUDs)...

  • Assessing the quality of human research protection programs to improve protection of human subjects participating in clinical trials. Tsan, Min-Fu; Tsan, Linda W // Clinical Trials;Jun2015, Vol. 12 Issue 3, p224 

    No abstract available.

  • TRIAL OF A SECONDARY STROKE PREVENTION PROGRAM.  // Ethnicity & Disease;Spring2011, Vol. 21 Issue 2, p248 

    The article discusses a randomized, controlled study on an outpatient stroke prevention program that started in March 2010 and will end in May 2012 for patients receiving care at Veterans Affairs (VA) Long Beach Healthcare System in Long Beach, California.

  • MESA'S MERCILESS MARCH. Barbella, Michael // Drug Topics;2/11/2008, Vol. 152 Issue 3, Special section p1 

    The article reports on efforts to control methicillin-resistant Staphylococcus aureus (MSRA) infection in the U.S. The Pharmaceutical Research and Manufacturers of America announced that research firms are testing 11 new drugs and four vaccines to treat MSRA infections. NovaBay Pharmaceuticals'...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics